NPI: 1376624981 · CENTRALIA, WA 98531 · General Acute Care Hospital · NPI assigned 10/18/2006
Authorized official ANDERSON, DONALD controls 20+ related entities in our dataset. Read more
| Authorized Official | ANDERSON, DONALD (ASSISTANT SECRETARY FOR ENROLLMENT) |
| NPI Enumeration Date | 10/18/2006 |
Other providers sharing the same authorized official: ANDERSON, DONALD
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 233,821 | $6.88M |
| 2019 | 236,664 | $6.47M |
| 2020 | 209,301 | $5.96M |
| 2021 | 221,844 | $5.89M |
| 2022 | 186,496 | $6.07M |
| 2023 | 138,172 | $4.62M |
| 2024 | 109,503 | $4.48M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| J9271 | Injection, pembrolizumab, 1 mg | 1,165 | 920 | $5.02M |
| 96361 | Intravenous infusion, hydration; each additional hour | 14,291 | 11,919 | $4.31M |
| 99283 | Emergency department visit for the evaluation and management, moderate severity | 29,601 | 28,123 | $3.24M |
| 99284 | Emergency department visit for the evaluation and management, high severity | 27,909 | 26,071 | $2.53M |
| 99285 | Emergency department visit for the evaluation and management, high severity with immediate threat to life | 25,690 | 23,540 | $2.18M |
| 59025 | Fetal non-stress test | 12,122 | 4,333 | $1.96M |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 9,503 | 9,195 | $1.51M |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 12,029 | 9,257 | $1.48M |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | 11,042 | 6,584 | $1.25M |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | 4,242 | 3,177 | $911K |
| 70450 | Computed tomography, head or brain; without contrast material | 7,117 | 6,755 | $868K |
| 96415 | 2,834 | 2,086 | $685K | |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 3,534 | 3,426 | $578K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 5,186 | 4,203 | $570K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 11,372 | 8,099 | $565K |
| 78815 | Positron emission tomography (PET) for limited area imaging | 1,106 | 1,089 | $503K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 11,289 | 4,950 | $482K |
| 77412 | 997 | 107 | $480K | |
| 76830 | Ultrasound, transvaginal | 4,816 | 4,757 | $418K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | 4,552 | 4,361 | $417K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 5,079 | 4,915 | $405K |
| 80053 | Comprehensive metabolic panel | 75,948 | 61,190 | $395K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 13,765 | 12,018 | $359K |
| 71275 | Computed tomographic angiography, chest, with contrast material | 2,384 | 2,318 | $355K |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | 7,905 | 3,371 | $353K |
| J2505 | Injection, pegfilgrastim, 6 mg | 203 | 150 | $296K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 1,257 | 1,248 | $276K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 1,877 | 1,807 | $237K |
| 96523 | 4,463 | 2,527 | $233K | |
| 87631 | 7,225 | 6,801 | $230K | |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | 5,495 | 5,423 | $229K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 3,155 | 3,026 | $224K |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | 3,028 | 2,912 | $206K |
| 45385 | Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) | 460 | 455 | $202K |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | 2,810 | 2,793 | $198K |
| 12001 | 884 | 876 | $197K | |
| J9355 | Injection, trastuzumab, excludes biosimilar, 10 mg | 211 | 102 | $191K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 516 | 510 | $182K |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | 3,048 | 2,994 | $176K |
| 76801 | 2,775 | 2,531 | $169K | |
| 93971 | 1,788 | 1,731 | $161K | |
| 77336 | 2,741 | 1,194 | $150K | |
| 71046 | Radiologic examination, chest; 2 views | 17,457 | 16,624 | $139K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 87,876 | 68,798 | $138K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 3,053 | 3,042 | $128K |
| J0185 | Injection, aprepitant, 1 mg | 1,374 | 942 | $122K |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | 2,556 | 2,469 | $122K |
| 76642 | 1,572 | 1,456 | $122K | |
| 36415 | Collection of venous blood by venipuncture | 56,285 | 44,026 | $119K |
| J0897 | Injection, denosumab, 1 mg | 366 | 331 | $107K |
| 84484 | 20,376 | 14,137 | $106K | |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | 263 | 261 | $104K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 6,267 | 6,121 | $98K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 4,559 | 2,023 | $89K |
| 93017 | 735 | 724 | $89K | |
| 76770 | 954 | 940 | $88K | |
| 71250 | 1,908 | 1,877 | $86K | |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | 564 | 556 | $83K |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | 273 | 270 | $77K |
| 74018 | 2,684 | 2,582 | $72K | |
| 97535 | Self-care/home management training, each 15 minutes | 2,970 | 1,878 | $71K |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | 696 | 693 | $71K |
| 77334 | 486 | 405 | $57K | |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | 930 | 849 | $55K |
| G0378 | Hospital observation service, per hour | 14,915 | 4,164 | $55K |
| 12002 | 262 | 257 | $53K | |
| 84443 | Thyroid stimulating hormone (TSH) | 10,235 | 9,527 | $53K |
| 10061 | 256 | 250 | $52K | |
| 73610 | 3,286 | 3,106 | $52K | |
| 83605 | 7,799 | 6,530 | $50K | |
| 80048 | Basic metabolic panel (calcium, ionized) | 9,656 | 7,449 | $48K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 6,981 | 4,449 | $47K |
| 87400 | 3,250 | 3,166 | $46K | |
| 73630 | 3,168 | 2,955 | $46K | |
| 73130 | 2,958 | 2,711 | $42K | |
| 73110 | 2,292 | 2,128 | $41K | |
| 87040 | 5,884 | 3,085 | $41K | |
| 72100 | 2,278 | 2,244 | $41K | |
| J1756 | Injection, iron sucrose, 1 mg | 1,734 | 844 | $40K |
| 73030 | 2,910 | 2,692 | $40K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 24,163 | 21,492 | $39K |
| 73562 | 2,305 | 2,242 | $39K | |
| 76536 | 419 | 415 | $39K | |
| 70496 | 363 | 351 | $38K | |
| 90715 | 2,196 | 2,177 | $38K | |
| J1453 | Injection, fosaprepitant, 1 mg | 313 | 199 | $38K |
| 70498 | 543 | 525 | $38K | |
| 36591 | 2,656 | 2,199 | $37K | |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | 1,115 | 1,019 | $35K |
| 86780 | 2,674 | 2,641 | $35K | |
| 97162 | 1,161 | 1,109 | $34K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 12,724 | 9,416 | $33K |
| 71271 | 417 | 415 | $33K | |
| 12011 | 120 | 119 | $31K | |
| 70551 | Magnetic resonance imaging, brain; without contrast material | 163 | 161 | $30K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 6,267 | 6,121 | $30K |
| J9035 | Injection, bevacizumab, 10 mg | 26 | 12 | $30K |
| 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 478 | 473 | $29K |
| 84702 | 4,269 | 3,551 | $29K | |
| 77290 | 115 | 103 | $29K | |
| 84145 | 3,110 | 2,923 | $28K | |
| 72125 | Computed tomography, cervical spine; without contrast material | 2,434 | 2,360 | $27K |
| 83880 | 5,543 | 5,103 | $27K | |
| 96367 | 2,521 | 1,862 | $26K | |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | 963 | 384 | $26K |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | 3,116 | 3,084 | $26K |
| 96375 | Therapeutic injection; each additional sequential IV push | 20,518 | 16,503 | $25K |
| 80050 | General health panel | 3,200 | 2,997 | $25K |
| 73140 | 1,342 | 1,295 | $25K | |
| 97166 | 740 | 711 | $24K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | 8,844 | 8,335 | $24K |
| 73502 | 1,756 | 1,658 | $24K | |
| 82728 | 4,414 | 4,155 | $24K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 21,701 | 19,441 | $23K |
| 85379 | 3,751 | 3,639 | $22K | |
| 77063 | Screening digital breast tomosynthesis, bilateral | 1,551 | 1,547 | $22K |
| 94770 | 265 | 234 | $22K | |
| C8929 | Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, complete, with spectral doppler echocardiography, and with color flow doppler echocardiography | 113 | 111 | $22K |
| 76882 | 272 | 249 | $22K | |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | 116 | 114 | $21K |
| 86803 | 2,913 | 2,884 | $21K | |
| 10060 | 93 | 90 | $21K | |
| 87653 | 1,308 | 1,300 | $21K | |
| 80061 | Lipid panel | 2,984 | 2,927 | $20K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | 1,141 | 468 | $20K |
| 70491 | 285 | 278 | $20K | |
| 76870 | 198 | 191 | $18K | |
| 86900 | 6,322 | 5,592 | $17K | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 2,908 | 2,885 | $17K |
| 83036 | Hemoglobin; glycosylated (A1C) | 3,923 | 3,866 | $17K |
| 86850 | 5,916 | 5,627 | $17K | |
| 84439 | 3,366 | 3,141 | $16K | |
| 77300 | 234 | 220 | $16K | |
| 77066 | Tomosynthesis, mammo | 590 | 588 | $16K |
| 72040 | 1,101 | 1,091 | $16K | |
| 70486 | 407 | 393 | $16K | |
| 87420 | 1,065 | 1,052 | $16K | |
| 82607 | 2,134 | 2,033 | $15K | |
| 58558 | 15 | 14 | $15K | |
| 87210 | 4,275 | 4,166 | $15K | |
| 85055 | 3,012 | 2,449 | $14K | |
| 85027 | 6,183 | 5,285 | $14K | |
| 37799 | 217 | 200 | $13K | |
| P9016 | Red blood cells, leukocytes reduced, each unit | 30 | 28 | $13K |
| 76819 | Fetal biophysical profile; without non-stress testing | 260 | 162 | $13K |
| 87070 | 4,555 | 4,375 | $13K | |
| 84466 | 3,802 | 3,625 | $13K | |
| 93970 | 126 | 123 | $11K | |
| 99195 | 241 | 200 | $11K | |
| 87340 | 3,367 | 3,321 | $11K | |
| 83735 | 9,070 | 6,321 | $11K | |
| 73090 | 898 | 830 | $11K | |
| 83540 | 4,137 | 3,942 | $11K | |
| 82731 | 601 | 550 | $10K | |
| 73590 | 1,068 | 973 | $10K | |
| 73080 | 864 | 836 | $10K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 1,371 | 1,340 | $10K |
| 86140 | 3,860 | 3,449 | $9K | |
| 82378 | 1,562 | 1,284 | $9K | |
| 86901 | 6,313 | 5,597 | $9K | |
| 72110 | 294 | 291 | $9K | |
| 82950 | 2,413 | 1,629 | $8K | |
| G0279 | Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | 700 | 693 | $8K |
| 73560 | 684 | 657 | $8K | |
| 85652 | 3,380 | 3,065 | $7K | |
| 87205 | 4,749 | 4,507 | $7K | |
| 71045 | Radiologic examination, chest; single view | 8,225 | 7,597 | $7K |
| 70470 | 78 | 76 | $7K | |
| 86762 | 2,077 | 2,049 | $7K | |
| G0297 | Low dose ct scan (ldct) for lung cancer screening | 62 | 61 | $7K |
| 72141 | 43 | 43 | $7K | |
| J1447 | Injection, tbo-filgrastim, 1 microgram | 46 | 12 | $6K |
| 82962 | 16,661 | 7,763 | $6K | |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | 29 | 26 | $6K |
| 73564 | 103 | 103 | $6K | |
| 96368 | 1,446 | 891 | $6K | |
| 96376 | 4,716 | 4,171 | $6K | |
| 96402 | 725 | 593 | $5K | |
| 87186 | 3,751 | 3,607 | $5K | |
| 81001 | 26,821 | 24,438 | $5K | |
| 87640 | 425 | 412 | $5K | |
| 74174 | 25 | 24 | $5K | |
| 97116 | 352 | 207 | $5K | |
| 36430 | 45 | 42 | $5K | |
| 83690 | 13,574 | 12,506 | $5K | |
| 84112 | 553 | 504 | $5K | |
| 20610 | 29 | 28 | $5K | |
| 99292 | 233 | 231 | $5K | |
| 72072 | 238 | 237 | $5K | |
| 82746 | 1,262 | 1,231 | $5K | |
| 83615 | 3,014 | 2,481 | $5K | |
| 64483 | 13 | 13 | $4K | |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 902 | 859 | $4K |
| 85610 | 11,181 | 7,977 | $4K | |
| 82105 | 378 | 363 | $4K | |
| 86300 | 333 | 287 | $4K | |
| 87081 | 1,593 | 1,576 | $4K | |
| 82570 | 1,427 | 1,248 | $4K | |
| 82784 | 472 | 347 | $3K | |
| 92523 | 27 | 27 | $3K | |
| 77065 | Tomosynthesis, mammo | 124 | 121 | $3K |
| 94726 | 83 | 83 | $3K | |
| 87077 | 3,217 | 3,030 | $3K | |
| 84403 | 224 | 218 | $3K | |
| 84156 | 1,208 | 903 | $3K | |
| 29125 | 12 | 12 | $3K | |
| 87176 | 882 | 823 | $3K | |
| 83883 | 403 | 308 | $3K | |
| 87641 | 427 | 412 | $3K | |
| 83001 | 167 | 167 | $2K | |
| 84100 | 2,326 | 1,732 | $2K | |
| 84165 | 482 | 431 | $2K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 2,099 | 2,035 | $2K |
| 82565 | 1,004 | 970 | $2K | |
| 97161 | 66 | 66 | $2K | |
| J3489 | Injection, zoledronic acid, 1 mg | 85 | 75 | $2K |
| 81025 | 12,420 | 11,692 | $2K | |
| 82247 | 240 | 180 | $2K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 124 | 118 | $2K |
| 77080 | 36 | 36 | $2K | |
| 82951 | 218 | 218 | $2K | |
| J3490 | Unclassified drugs | 1,299 | 1,174 | $2K |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 14,869 | 13,280 | $2K |
| 94729 | 86 | 86 | $2K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 2,582 | 2,431 | $2K |
| 86304 | 197 | 172 | $2K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 18,152 | 14,245 | $2K |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | 161 | 157 | $2K |
| 36592 | 478 | 362 | $2K | |
| J2997 | Injection, alteplase recombinant, 1 mg | 48 | 38 | $2K |
| 86706 | 815 | 796 | $2K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 2,828 | 2,782 | $2K |
| 87486 | 93 | 92 | $1K | |
| 72131 | 28 | 28 | $1K | |
| 97750 | 69 | 65 | $1K | |
| 92558 | 12 | 12 | $1K | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 16,014 | 15,172 | $1K |
| 86704 | 770 | 747 | $1K | |
| 82805 | 4,398 | 3,770 | $1K | |
| 84146 | 94 | 92 | $1K | |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | 9,069 | 7,555 | $1K |
| 82550 | 1,266 | 1,062 | $1K | |
| 74022 | 247 | 246 | $1K | |
| 74019 | 119 | 118 | $1K | |
| 87522 | Neg quan hep c or qual rna | 80 | 80 | $1K |
| 87147 | 1,527 | 1,470 | $1K | |
| 81003 | 2,853 | 2,396 | $1K | |
| 82248 | 285 | 236 | $960.83 | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | 110 | 107 | $948.51 |
| 84703 | 2,970 | 2,885 | $944.05 | |
| 85730 | 1,486 | 1,409 | $911.33 | |
| 94060 | 28 | 27 | $906.71 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 7,789 | 7,092 | $899.21 |
| 84155 | 520 | 469 | $874.29 | |
| A9585 | Injection, gadobutrol, 0.1 ml | 1,254 | 1,222 | $849.03 |
| J7030 | Infusion, normal saline solution , 1000 cc | 15,520 | 12,304 | $824.90 |
| 80164 | 81 | 70 | $814.32 | |
| 73700 | 13 | 13 | $780.16 | |
| 87581 | 93 | 92 | $757.90 | |
| 73660 | 28 | 27 | $756.62 | |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 3,341 | 3,164 | $747.18 |
| J2704 | Injection, propofol, 10 mg | 6,591 | 6,334 | $735.24 |
| 84153 | 204 | 190 | $719.48 | |
| 84550 | 607 | 479 | $696.25 | |
| 92522 | 13 | 13 | $694.47 | |
| 86592 | 122 | 121 | $668.44 | |
| 87109 | 47 | 46 | $644.24 | |
| 93225 | 15 | 15 | $643.44 | |
| A9270 | Non-covered item or service | 18,606 | 3,360 | $640.86 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 11,009 | 8,354 | $625.13 |
| 87088 | 232 | 220 | $614.74 | |
| 97163 | 28 | 28 | $555.36 | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 6,337 | 4,793 | $552.84 |
| 86141 | 389 | 381 | $532.21 | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 14 | 14 | $529.76 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 6,007 | 5,706 | $516.27 |
| 93016 | 50 | 50 | $492.59 | |
| J2310 | Injection, naloxone hydrochloride, per 1 mg | 17 | 13 | $461.36 |
| J0690 | Injection, cefazolin sodium, 500 mg | 3,973 | 3,250 | $455.95 |
| 83970 | 18 | 16 | $448.88 | |
| J2270 | Injection, morphine sulfate, up to 10 mg | 6,164 | 4,657 | $431.35 |
| 90686 | 50 | 50 | $422.44 | |
| 88307 | 28 | 28 | $393.13 | |
| 80076 | 68 | 63 | $392.77 | |
| 94010 | 12 | 12 | $387.81 | |
| 72050 | 12 | 12 | $385.55 | |
| 86923 | 26 | 24 | $377.24 | |
| 96417 | 3,140 | 2,026 | $366.89 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 5,368 | 3,967 | $360.29 |
| J1170 | Injection, hydromorphone, up to 4 mg | 4,907 | 3,519 | $358.84 |
| C1713 | Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) | 326 | 321 | $343.56 |
| 93226 | 15 | 15 | $339.57 | |
| 93018 | 50 | 50 | $322.69 | |
| 83516 | 45 | 24 | $307.16 | |
| 80178 | 31 | 24 | $286.76 | |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | 2,870 | 2,552 | $285.44 |
| J8540 | Dexamethasone, oral, 0.25 mg | 6,262 | 3,275 | $264.46 |
| C9113 | Injection, pantoprazole sodium, per vial | 669 | 516 | $258.34 |
| 36593 | 19 | 14 | $253.28 | |
| 82627 | 12 | 12 | $250.11 | |
| J1642 | Injection, heparin sodium, (heparin lock flush), per 10 units | 15,458 | 8,222 | $231.14 |
| J7120 | Ringers lactate infusion, up to 1000 cc | 6,599 | 5,885 | $223.41 |
| J1439 | Injection, ferric carboxymaltose, 1 mg | 78 | 58 | $213.33 |
| 36600 | 3,130 | 2,750 | $209.73 | |
| 87521 | Neg quan hep c or qual rna | 12 | 12 | $203.24 |
| 85014 | 1,075 | 921 | $201.49 | |
| 86708 | 55 | 54 | $191.10 | |
| J0330 | Injection, succinylcholine chloride, up to 20 mg | 501 | 492 | $179.38 |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | 1,634 | 1,310 | $165.41 |
| 96521 | 189 | 112 | $146.13 | |
| Q9957 | Injection, perflutren lipid microspheres, per ml | 154 | 152 | $144.82 |
| 86308 | 66 | 63 | $143.71 | |
| 82952 | 96 | 96 | $141.43 | |
| J2785 | Injection, regadenoson, 0.1 mg | 166 | 164 | $139.06 |
| J7050 | Infusion, normal saline solution, 250 cc | 24,262 | 7,897 | $135.34 |
| J0780 | Injection, prochlorperazine, up to 10 mg | 673 | 636 | $132.83 |
| 83002 | 12 | 12 | $132.39 | |
| 82140 | 66 | 54 | $125.13 | |
| 96411 | 1,262 | 850 | $123.26 | |
| 71101 | 27 | 27 | $120.61 | |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | 428 | 321 | $104.12 |
| 87075 | 299 | 279 | $99.61 | |
| J1630 | Injection, haloperidol, up to 5 mg | 954 | 787 | $94.15 |
| 73552 | 13 | 12 | $86.99 | |
| 85018 | 1,062 | 911 | $78.87 | |
| J2060 | Injection, lorazepam, 2 mg | 3,301 | 2,666 | $78.71 |
| 86003 | 13 | 13 | $73.32 | |
| J9045 | Injection, carboplatin, 50 mg | 1,038 | 663 | $72.96 |
| A9552 | Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 1,229 | 1,212 | $66.50 |
| J1815 | Injection, insulin, per 5 units | 3,362 | 1,465 | $61.33 |
| 81015 | 224 | 218 | $56.19 | |
| 88304 | 506 | 503 | $55.84 | |
| 82150 | 13 | 13 | $55.33 | |
| 87493 | 13 | 13 | $51.15 | |
| 82010 | 269 | 242 | $47.36 | |
| 83550 | 12 | 12 | $47.23 | |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | 3,707 | 2,783 | $45.90 |
| 80143 | 66 | 62 | $34.34 | |
| 85046 | 12 | 12 | $32.46 | |
| J1644 | Injection, heparin sodium, per 1000 units | 4,572 | 1,510 | $28.47 |
| 82803 | 290 | 246 | $26.36 | |
| J3370 | Injection, vancomycin hcl, 500 mg | 655 | 399 | $25.66 |
| 80179 | 65 | 61 | $17.11 | |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | 5,271 | 2,955 | $16.66 |
| J3475 | Injection, magnesium sulfate, per 500 mg | 3,156 | 1,968 | $12.82 |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | 1,847 | 1,393 | $10.78 |
| 94761 | 4,989 | 2,716 | $9.81 | |
| 82270 | 41 | 39 | $7.76 | |
| J2550 | Injection, promethazine hcl, up to 50 mg | 424 | 379 | $7.00 |
| J2710 | Injection, neostigmine methylsulfate, up to 0.5 mg | 143 | 141 | $3.10 |
| J2795 | Injection, ropivacaine hydrochloride, 1 mg | 266 | 175 | $2.78 |
| J3480 | Injection, potassium chloride, per 2 meq | 2,192 | 1,241 | $2.53 |
| J1940 | Injection, furosemide, up to 20 mg | 218 | 148 | $0.00 |
| J7060 | 5% dextrose/water (500 ml = 1 unit) | 744 | 226 | $0.00 |
| G8987 | Self care functional limitation, current status, at therapy episode outset and at reporting intervals | 82 | 78 | $0.00 |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 384 | 314 | $0.00 |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 1,793 | 1,719 | $0.00 |
| J2370 | Injection, phenylephrine hcl, up to 1 ml | 255 | 249 | $0.00 |
| J2543 | Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) | 406 | 174 | $0.00 |
| 72170 | 13 | 13 | $0.00 | |
| J9267 | Injection, paclitaxel, 1 mg | 629 | 280 | $0.00 |
| J7999 | Compounded drug, not otherwise classified | 152 | 145 | $0.00 |
| J1790 | Injection, droperidol, up to 5 mg | 111 | 101 | $0.00 |
| J2371 | Injection, phenylephrine hydrochloride, 20 micrograms | 27 | 27 | $0.00 |
| 82330 | 63 | 63 | $0.00 | |
| J2470 | Injection, pantoprazole sodium, 40 mg | 53 | 41 | $0.00 |
| C9463 | Injection, aprepitant, 1 mg | 36 | 25 | $0.00 |
| 82077 | 87 | 84 | $0.00 | |
| G8988 | Self care functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting | 83 | 79 | $0.00 |
| 88720 | 12 | 12 | $0.00 | |
| C1781 | Mesh (implantable) | 13 | 13 | $0.00 |
| J1836 | Injection, metronidazole, 10 mg | 34 | 15 | $0.00 |
| G1004 | Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program | 13,831 | 12,605 | $0.00 |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 84 | 83 | $0.00 |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | 129 | 113 | $0.00 |
| J9190 | Injection, fluorouracil, 500 mg | 274 | 100 | $0.00 |
| G8979 | Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting | 278 | 254 | $0.00 |
| J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | 318 | 260 | $0.00 |
| G0500 | Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intra-service time; patient age 5 years or older (additional time may be reported with 99153, as appropriate) | 622 | 614 | $0.00 |
| G8978 | Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals | 275 | 253 | $0.00 |
| J1650 | Injection, enoxaparin sodium, 10 mg | 2,439 | 642 | $0.00 |
| J0171 | Injection, adrenalin, epinephrine, 0.1 mg | 68 | 59 | $0.00 |
| J0688 | Injection, cefazolin sodium (hikma), not therapeutically equivalent to j0690, 500 mg | 78 | 65 | $0.00 |
| 87150 | 28 | 12 | $0.00 | |
| J0640 | Injection, leucovorin calcium, per 50 mg | 119 | 36 | $0.00 |
| Q9966 | Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml | 69 | 69 | $0.00 |
| J1596 | Injection, glycopyrrolate, 0.1 mg | 38 | 38 | $0.00 |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | 13 | 13 | $0.00 |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | 15 | 12 | $0.00 |
| J1171 | Injection, hydromorphone, 0.1 mg | 44 | 37 | $0.00 |
| J2004 | Injection, lidocaine hcl with epinephrine, 1 mg | 32 | 32 | $0.00 |